CoChat

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; 9 of the 17 sources its claims cite were checked for support.

Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells

Open access

Abstract

Genome lesions trigger biological responses that help cells manage damaged DNA, improving cell survival. Pol eta is a translesion synthesis (TLS) polymerase that bypasses lesions that block replicative polymerases, avoiding continued stalling of replication forks, which could lead to cell death. p53 also plays an important role in preventing cell death after ultraviolet (UV) light exposure. Intriguingly, we show that p53 does so by favoring translesion DNA synthesis by pol eta. In fact, the p53-dependent induction of pol eta in normal and DNA repair-deficient XP-C human cells after UV exposure has a protective effect on cell survival after challenging UV exposures, which was absent in p53- and Pol H-silenced cells. Viability increase was associated with improved elongation of nascent DNA, indicating the protective effect was due to more efficient lesion bypass by pol eta. This protection was observed in cells proficient or deficient in nucleotide excision repair, suggesting that, from a cell survival perspective, proper bypass of DNA damage can be as relevant as removal. These results indicate p53 controls the induction of pol eta in DNA damaged human cells, resulting in improved TLS and enhancing cell tolerance to DNA damage, which parallels SOS responses in bacteria.

Overview

CoChat Summary

TL;DR

In human fibroblasts and melanoma cells, UV or cisplatin induces DNA polymerase eta (pol eta) in a p53-dependent manner, and p53 is also required for pol eta chromatin recruitment. A low-dose UVC pre-treatment improves survival and nascent DNA elongation after a higher challenging dose through p53- and pol eta-dependent translesion synthesis, even in NER-deficient XP-C cells.

Key findings

  • UVC, UVB, or cisplatin increased pol eta protein levels 2- to 3-fold at 24 h in NER-proficient WT and NER-deficient XP-C primary fibroblasts; induction was abolished by p53 inhibition/silencing and absent in p53-mutated SK-MEL-28 cells, but restored by wild-type p53 transduction.
  • In UVC split-dose experiments, XP-C cells pre-irradiated with 6 J/m² and challenged 24 h later with 20 or 40 J/m² showed reduced SubG1 apoptosis and better survival than cells receiving only the challenging dose; the pre-dose caused <5% cell death. These protective effects were p53-dependent.
  • Pre-irradiated cells progressed through the cell cycle, nearly doubling the proportion in late S and G2 after challenge, whereas a single 46 J/m² dose strongly arrested cells in G1. DNA fiber assays showed a CldU/IdU ratio of 0.33 in non-irradiated cells, and pre-irradiation reduced CldU/IdU ratios, indicating improved elongation across UV lesions in WT and XP-C cells but not in p53-silenced cells.
  • POLH silencing abolished protection in XP-C cells, and NER-proficient XP-V cells were not protected by pre-treatment (10 J/m² before 40 or 60 J/m²). XP-A cells, deficient in transcription-coupled repair, were also not protected by pre-doses of 1 or 3 J/m². REV1 mRNA increased after UVC in a p53-dependent manner; POLK and POLI were induced in control fibroblasts but not in XP-V or XP-C cells.

Methods

  • Cell models included primary human XP-C fibroblasts XP189VI, primary wild-type skin fibroblasts, XP-V primary fibroblasts XP05MG, complemented XP30RO-SV cells, and melanoma lines SK-MEL-28 and SK-MEL-27; p53 and POLH were silenced with lentiviral shRNA.
  • Cells were treated with UVC, UVB, or cisplatin, and UVC split-dose protocols were used with pre-doses followed by challenging doses. Assays included flow cytometry for cell cycle and SubG1, PI-BrdU staining, DNA fiber assays with CldU/IdU pulses, Western blot, chromatin fractionation, and Real-Time PCR.
  • Statistical significance was determined using one-way ANOVA followed by Tukey’s Multiple Comparison Test in GraphPad Prism 5.

Limitations

  • The paper states that it was not able to evaluate whether the induction is mutagenic, although it notes pol eta is almost error-free for UV-induced CPDs and prior work indicated overexpression does not increase mutagenesis in human cells.
  • For the TLS polymerase mRNA experiments, the paper states that these do not reflect protein levels, activity, or protein modifications, and that protein levels should be monitored to conclude on regulation of function.
  • Evident from the text: the study is entirely cell-culture based, uses artificial split-dose UVC regimens, and relies heavily on shRNA silencing and Supplementary Figures for several key controls and results.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/nar/gkw1196

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. P53-dependent induction of DNA pol eta after the UV irradiation of human fibroblasts. (A) Pol eta is induced by UVC in primary fibroblasts. Pol eta was detected by western blot after irradiation with 6 J/m2 (XP-C) and 40 J/m2 (WT) UVC; the samples were collected 0, 5 and 24 h after treatment. The pol eta protein was undetectable in the XP-V cell line. (B) Kinetics of Pol eta induction. XP-C cells were treated with 6 J/m2 and harvested at the indicated time points. (C) Left panel: Western blot analysis of the total protein content from XP-C cells that were silenced for p53 (shp53) with lentiviral vectors. The cells were treated with 6 J/m2 and harvested 24 h later. Right panel: pol eta induction is absent in p53-silenced XP-C primary fibroblasts. The cells were treated with 6 J/m2 and harvested at the indicated time points. (D) POLH mRNA transcription increased after UVC treatment. The cells were treated with 6 J/m2 (XP-C and p53 shRNA XP-C) and 40 J/m2 (WT) and collected at the indicated time points. mRNA transcription was quantified as the relative expression compared with that of the respective non-irradiated controls. The values represent the means (error bars indicate SD) of three independent experiments. *** P < 0.001.
Figure 1. P53-dependent induction of DNA pol eta after the UV irradiation of human fibroblasts. (A) Pol eta is induced by UVC in primary fibroblasts. Pol eta was detected by western blot after irradiation with 6 J/m2 (XP-C) and 40 J/m2 (WT) UVC; the samples were collected 0, 5 and 24 h after treatment. The pol eta protein was undetectable in the XP-V cell line. (B) Kinetics of Pol eta induction. XP-C cells were treated with 6 J/m2 and harvested at the indicated time points. (C) Left panel: Western blot analysis of the total protein content from XP-C cells that were silenced for p53 (shp53) with lentiviral vectors. The cells were treated with 6 J/m2 and harvested 24 h later. Right panel: pol eta induction is absent in p53-silenced XP-C primary fibroblasts. The cells were treated with 6 J/m2 and harvested at the indicated time points. (D) POLH mRNA transcription increased after UVC treatment. The cells were treated with 6 J/m2 (XP-C and p53 shRNA XP-C) and 40 J/m2 (WT) and collected at the indicated time points. mRNA transcription was quantified as the relative expression compared with that of the respective non-irradiated controls. The values represent the means (error bars indicate SD) of three independent experiments. *** P < 0.001.CC BY-NC · PubMed Central
Figure 2. The delivery of UVC split doses increases cell survival and DNA replication in p53-WT cells. (A) Scheme of the experimental UV split-dose procedure. (B) UVC split doses decrease cell death after challenging UVC irradiation in p53-WT cells. Percentages of the hypodiploid cells (SubG1) fraction were detected by flow cytometry 72 h after the challenging dose. p53 was depleted in XP-C cells by the lentiviral delivery of short-hairpin RNA sequences. The values represent the means (error bars indicate SD) of three independent experiments. *P < 0.05 and ***P < 0.001. (C) Cell survival 24, 48 and 72 h after the indicated single- or split-UVC doses (in J/m2) as described in the Materials and Methods. ** P < 0.01 and ***P < 0.001. (D) DNA replication in cells that were submitted to UVC split doses increased after challenging UVC doses. The cell cycle phase distribution and S-phase cell progression of XP-C cells were evaluated after BrdU incorporation that immediately followed the challenging UV dose and PI staining. Samples were collected and fixed 24 h after the BrdU pulse. The upper left panel shows an example of the quantification of G1, S and G2-phase populations and the corresponding values in %. Representative plots of three independent experiments are shown, with the DNA content on the X-axis and the BrdU incorporation on the Y-axis. The corresponding cell-cycle distribution as determined by PI staining is shown in the top right corner of each graph. (E) shp53 XP-C cells did not show increased DNA replication after UVC split doses. The experimental procedure was as described in (D).
Figure 2. The delivery of UVC split doses increases cell survival and DNA replication in p53-WT cells. (A) Scheme of the experimental UV split-dose procedure. (B) UVC split doses decrease cell death after challenging UVC irradiation in p53-WT cells. Percentages of the hypodiploid cells (SubG1) fraction were detected by flow cytometry 72 h after the challenging dose. p53 was depleted in XP-C cells by the lentiviral delivery of short-hairpin RNA sequences. The values represent the means (error bars indicate SD) of three independent experiments. *P < 0.05 and ***P < 0.001. (C) Cell survival 24, 48 and 72 h after the indicated single- or split-UVC doses (in J/m2) as described in the Materials and Methods. ** P < 0.01 and ***P < 0.001. (D) DNA replication in cells that were submitted to UVC split doses increased after challenging UVC doses. The cell cycle phase distribution and S-phase cell progression of XP-C cells were evaluated after BrdU incorporation that immediately followed the challenging UV dose and PI staining. Samples were collected and fixed 24 h after the BrdU pulse. The upper left panel shows an example of the quantification of G1, S and G2-phase populations and the corresponding values in %. Representative plots of three independent experiments are shown, with the DNA content on the X-axis and the BrdU incorporation on the Y-axis. The corresponding cell-cycle distribution as determined by PI staining is shown in the top right corner of each graph. (E) shp53 XP-C cells did not show increased DNA replication after UVC split doses. The experimental procedure was as described in (D).CC BY-NC · PubMed Central
Figure 3. UVC pre-irradiation decreases replication fork arrest after challenging UVC doses in p53-WT cells. (A) Scheme of the DNA fiber experiment. The lightening represents the UVC irradiation. (B) Cumulative frequency distribution of the CldU/IdU ratio expressed as the percentage of cumulative forks; (C) distribution of the CldU/IdU ratios for WT, XP-C and XP-C shp53 cells; and (D) average CldU/IdU ratio. The length of the CldU track is the same for all of the cell groups. The values represent the means (error bars indicate SD) of two independent experiments. ***P < 0.001.
Figure 3. UVC pre-irradiation decreases replication fork arrest after challenging UVC doses in p53-WT cells. (A) Scheme of the DNA fiber experiment. The lightening represents the UVC irradiation. (B) Cumulative frequency distribution of the CldU/IdU ratio expressed as the percentage of cumulative forks; (C) distribution of the CldU/IdU ratios for WT, XP-C and XP-C shp53 cells; and (D) average CldU/IdU ratio. The length of the CldU track is the same for all of the cell groups. The values represent the means (error bars indicate SD) of two independent experiments. ***P < 0.001.CC BY-NC · PubMed Central
Figure 4. Pol eta is required to improve the cell survival of GG-NER-deficient cells after split-dose treatment. (A) Western blot analysis of the total protein content from XP-C cells that were silenced for POLH (shPOLH) with lentiviral vectors. (B) SubG1 population was detected 72 h after UVC treatment with the indicated doses in XP-C control sh and XP-C shPOLH cells. The values represent the means (error bars indicate SD) of three independent experiments. The cell proliferation of POLH-silenced XP-C cells was determined 24, 48 and 72 h after the indicated single of split-doses of UVC (in J/m2). ***P < 0.001. (C) UVC split-dose effects on the cell cycle and DNA replication depend on pol eta in XP-C cells. The cell cycle phase distribution and S-phase cell progression of XP-C cells were evaluated by PI staining and BrdU incorporation immediately after the challenging UV dose. (D) UVC pre-irradiation has no effect in replication fork arrest after challenging UVC doses in POLH-depleted XP-C cells. Cumulative frequency distribution of the CldU/IdU ratio expressed as the percentage of cumulative forks (left panel), and average CldU/IdU ratio (right panel) for XP-C shPOLH cells. The values represent the means (error bars indicate SD) of two independent experiments. (E) Split-dose protective effects are lost in XP-V cells, particularly at higher UVC doses. The SubG1 population was detected as described above. The values represent the means (error bars indicate SD) of three independent experiments.
Figure 4. Pol eta is required to improve the cell survival of GG-NER-deficient cells after split-dose treatment. (A) Western blot analysis of the total protein content from XP-C cells that were silenced for POLH (shPOLH) with lentiviral vectors. (B) SubG1 population was detected 72 h after UVC treatment with the indicated doses in XP-C control sh and XP-C shPOLH cells. The values represent the means (error bars indicate SD) of three independent experiments. The cell proliferation of POLH-silenced XP-C cells was determined 24, 48 and 72 h after the indicated single of split-doses of UVC (in J/m2). ***P < 0.001. (C) UVC split-dose effects on the cell cycle and DNA replication depend on pol eta in XP-C cells. The cell cycle phase distribution and S-phase cell progression of XP-C cells were evaluated by PI staining and BrdU incorporation immediately after the challenging UV dose. (D) UVC pre-irradiation has no effect in replication fork arrest after challenging UVC doses in POLH-depleted XP-C cells. Cumulative frequency distribution of the CldU/IdU ratio expressed as the percentage of cumulative forks (left panel), and average CldU/IdU ratio (right panel) for XP-C shPOLH cells. The values represent the means (error bars indicate SD) of two independent experiments. (E) Split-dose protective effects are lost in XP-V cells, particularly at higher UVC doses. The SubG1 population was detected as described above. The values represent the means (error bars indicate SD) of three independent experiments.CC BY-NC · PubMed Central
Figure 5. Proposed model for the cellular responses leading to improved DNA damage replication and cell tolerance after UVC split-dose. (A) After a high UVC dose, the genotoxic load leads to the arrest of the replication fork and the blockage of cells in G1 and early S-phase of the cell cycle; the persistence of the blocked replication fork ultimately causes cell death. (B) In cells that were previously treated with low UVC doses, DNA damage leads to the stabilization and transactivation of p53, the master regulator of the adaptive response, by activated kinases (not shown). p53 stabilization leads to changes in gene expression, including increased expression of repair proteins, such as XPC and DDB2, as well as TLS polymerases, such as pol eta and REV1. When confronted with the next higher UVC dose, cells are able to better address the genotoxic stress. Less replication fork arrest, due to increased ability to progress in the cell cycle, consequently leads to higher DNA replication rates, which has a protective effect on cell survival.
Figure 5. Proposed model for the cellular responses leading to improved DNA damage replication and cell tolerance after UVC split-dose. (A) After a high UVC dose, the genotoxic load leads to the arrest of the replication fork and the blockage of cells in G1 and early S-phase of the cell cycle; the persistence of the blocked replication fork ultimately causes cell death. (B) In cells that were previously treated with low UVC doses, DNA damage leads to the stabilization and transactivation of p53, the master regulator of the adaptive response, by activated kinases (not shown). p53 stabilization leads to changes in gene expression, including increased expression of repair proteins, such as XPC and DDB2, as well as TLS polymerases, such as pol eta and REV1. When confronted with the next higher UVC dose, cells are able to better address the genotoxic stress. Less replication fork arrest, due to increased ability to progress in the cell cycle, consequently leads to higher DNA replication rates, which has a protective effect on cell survival.CC BY-NC · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 3 Not checked · 27 Own results and interpretations

15 more claims

Create a free account to see all 38 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 15
  • Probably not a substantial claim. 6
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 45 references

Cited by

See all 54

Metadata

Authors
Lerner, L. K., Francisco, G., Soltys, D. T., Rocha, C. R. R., Quinet, A., Vessoni, A. T., Castro, L. P., David, T. I. P., Bustos, S. O., Strauss, B. E., Gottifredi, V., Stary, A., Sarasin, A., Chammas, R., & Menck, C. F. M.
Affiliations
  • Instituto do Câncer do Estado de São Paulo (BR)
  • Universidade de São Paulo (BR)
  • Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
  • Université Paris-Sud (FR)
Corresponding author
Menck, Carlos F.M.
Venue
Nucleic Acids Research
Published
2016-12-03
Volume
45
Issue
3
Pages
1270-1280
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2559912224
Cited by
53
References
45
Citations by year
2026: 3 · 2025: 6 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 11 · 2019: 4 · 2018: 8 · 2017: 5
FWCI
2.94
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, cc-by-nc-sa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (13/21075-9, 2014/, 14/15982-6)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Centre National de la Recherche Scientifique
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords
DNA polymerase eta, p53, translesion synthesis, UV irradiation, cell survival, DNA damage tolerance, nucleotide excision repair, xeroderma pigmentosum complementation group C, replication fork stalling, SOS response
MeSH terms
Y-Family DNA Polymerases, Cell Line, Cell Survival, Chromatin, DNA, DNA-Directed DNA Polymerase, DNA Repair, DNA Replication, Dose-Response Relationship, Radiation, Fibroblasts, Gene Expression Regulation, Humans, Ultraviolet Rays, Tumor Suppressor Protein p53

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells. https://app.cochat.ai/papers/10.1093/nar/gkw1196
The paper
Lerner, L. K., Francisco, G., Soltys, D. T., Rocha, C. R. R., Quinet, A., Vessoni, A. T., Castro, L. P., David, T. I. P., Bustos, S. O., Strauss, B. E., Gottifredi, V., Stary, A., Sarasin, A., Chammas, R., & Menck, C. F. M. (2017). Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells. Nucleic Acids Research. https://doi.org/10.1093/nar/gkw1196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.